Entering text into the input field will update the search result below

Kaleyra stock jumps on TCR Acquisition's offer to acquire Campaign Registry for $19.46M

Jul. 12, 2022 1:22 PM ETKaleyra, Inc. (KLR)By: Jessica Kuruthukulangara, SA News Editor10 Comments
  • Kaleyra (NYSE:KLR) stock jumped 12.5% on Tuesday after TCR Acquisition made a formal offer to acquire the operating business of Campaign Registry from KLR for $19.46M.
  • The proposed purchase price reflects ~25% of KLR's total market cap.
  • Campaign Registry works

Recommended For You

Comments (10)

Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

Quite interesting to see this down so much today after rejecting a $20 million offer for a small sliver of their business because they believe it is worth even more.

Current market cap is $90 million. Current EV is $220 million. Assuming $50 million is Campaign Registry, then the core business trades at $170 million while generating $300+ million a year in revenue. What am I missing here?
Ruben123 profile picture
@Invest Slowly Picks Market is just giving you an oppurtunity to add. Look back to your own post after 3 years.
Offer according to Reuters denied!
Hope they reject this. TCR is the most valuable asset of Kaleyra.
KLR should not accept this offer.
Based on the below statement, can KLR be forced to sell the Campaign registry?

"Campaign Registry's operations and network constitute 'critical infrastructure' of importance to national security. While current foreign ownership of Campaign Registry has never undergone a CFIUS review, it must be independently owned by a U.S. entity," said TCR CEO Frederick Joyce.
@AN123 don't think so, but if I would be the CEO of the buyer, I would say the same ;)

Long KLR
dachorses profile picture
The pain continues
That's a ridiculous offer for CR...hopefully that offer is rejected
Ruben123 profile picture
KLR is so undervalued. The stock price increase by 10x and it would still be very undervalued.

Related Stocks

SymbolLast Price% Chg
Kaleyra, Inc.
SomaLogic, Inc.
Nautilus Biotechnology, Inc.
Arqit Quantum Inc.
Coda Octopus Group, Inc.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.